Search results
Showing 1 to 3 of 3 results for somatrogon
Evidence-based recommendations on somatrogon (Ngenla) for treating growth disturbance in children and young people aged 3 years and over.
Somapacitan for treating growth hormone deficiency in children [ID6178]
In development [GID-TA11153] Expected publication date: TBC
NICE recommends a weekly injection for treating growth failure in children
This recommendation comes from a pilot to develop simpler, faster evaluations for the appraisal of some treatments.